Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has collaborated with B. Braun Medical, located in Bethlehem, PA, USA. The company recently launched its prefilled syringe of Heparin Sodium Injection, USP utilizing Schreiner MediPharm's label-integrated Needle-Trap system to the US market.
According to B. Braun, this is the first prefilled heparin syringe with an integrated needle protection device approved by the US Food and Drug Administration (FDA).
In the United States, syringes should be used with safety devices to protect healthcare staff against the risk of needlestick injuries. B. Braun Medical was looking for an efficient and safe needle protection solution for its prefilled Heparin Sodium Injection and found it in Needle-Trap from Schreiner MediPharm.
The Needle-Trap system is an internationally established solution that complies with the US NIOSH requirements for safe instruments and has been awarded 510(k) Pre-Market Notification by the FDA for marketing in the United States. "Clinical staff benefit from reliable protection against needlestick injuries because Needle-Trap's activation is easy and irreversible. It is intuitive to use and requires no change in injection...